ЦЗЯ Юн (US),КАСИБХАТЛА Схайладжа (US),БАЙЛИК Сэйнела (US),КЭМЕРОН Джон (US),ХОВАРД МЛ. Дэнни (US)
申请号：
RU2018105846
公开号：
RU2018105846A
申请日:
2016.07.27
申请国别(地区):
RU
年份:
2019
代理人:
摘要：
The present invention relates to a pharmaceutical composition comprising PD-1 antagonist and an EGFR Inhibitor. The present combination can be administered independently or separately, in a quantity which is jointly therapeutically effective for the treatment of cancer. The invention also provides the use of such a combination for the manufacture of a medicament； the use of such a combination as a medicine； a kit of part comprising such a combination； and a method of treatment of such a combination.
